… corticobasal degeneration, dementia with Lewy bodies, multiple system atrophy and progressive supranuclear palsy. These …

… disease with deficits in motor, sleep, cognitive, and other systems, we propose to establish a “platform” of models to … in combination with levodopa may improve PD treatment in multiple ways. During the day, MLR-1017 administration would …  MLR-1017 showed both behavioral and biochemical benefit in multiple experiments that modeled Parkinson’s-like symptoms. …

… by the FDA for Phase I studies in humans, works through multiple mechanisms of benefit, including immune modulation … neuroprotection, in pre-clinical models of central nervous system (CNS) injury and disease. Translationally relevant … administration provides documented therapeutic benefit in multiple models of CNS disease and injury, including stroke, …

… acid esters are also currently being tested clinically for multiple sclerosis and psoriasis (in fact, they’ve been … been shown to have adverse effects on the gastrointestinal system in previous clinical trials, but early pre-clinical …

… his current research focuses on human corticospinal (brain system) physiology (function), particularly brainstem and … numerous awards for his scientific achievements, including multiple awards from international institutions. …

… (PD). However, achieving reliable, chronic central nervous system (CNS) delivery for macromolecules such as antibodies … peripheral tissue levels will be measured and mapped using multiple technologies. Control experiments will be performed … to the brain of pre-clinical models and achieve levels in multiple brain areas that might be expected to have …